[{"address1": "650 Chapel Street", "address2": "Suite 0403, Level 4", "city": "South Yarra", "state": "VIC", "zip": "3141", "country": "Australia", "phone": "61 3 9826 0399", "fax": "61 3 9824 0083", "website": "https://opthea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Dr. Frederic  Guerard M.S., Pharm.D.", "age": 52, "title": "Chief Executive Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 775570, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Megan  Baldwin M.A.I.C.D., MAICD, Ph.D.", "age": 49, "title": "Founder & Chief Innovation Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 602175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen  Adams CPA", "age": 53, "title": "VP of Finance & Company Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 304370, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas Charles Reilly", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Bitter", "age": 32, "title": "VP of Strategy & Corporate Development", "yearBorn": 1992, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anand  Sundaram", "title": "Vice President Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fang  Li Ph.D.", "age": 60, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Julie  Clark M.D., M.S.", "age": 49, "title": "Senior Vice President of Clinical Development", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jen  Watts", "title": "VP Global Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dayong  Li Ph.D.", "title": "Senior VP, Biometrics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.circadian.com.au/investor-information", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.1, "open": 3.22, "dayLow": 3.03, "dayHigh": 3.4503, "regularMarketPreviousClose": 3.1, "regularMarketOpen": 3.22, "regularMarketDayLow": 3.03, "regularMarketDayHigh": 3.4503, "payoutRatio": 0.0, "beta": 1.639, "forwardPE": -1.7189189, "volume": 86389, "regularMarketVolume": 86389, "averageVolume": 34221, "averageVolume10days": 61400, "averageDailyVolume10Day": 61400, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 489421088, "fiftyTwoWeekLow": 1.79, "fiftyTwoWeekHigh": 6.3, "priceToSalesTrailing12Months": 2343.3086, "fiftyDayAverage": 4.43704, "twoHundredDayAverage": 3.489505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4006213632, "profitMargins": 0.0, "floatShares": 785981303, "sharesOutstanding": 153906000, "sharesShort": 432797, "sharesShortPriorMonth": 420114, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0028, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.03679, "shortRatio": 14.29, "shortPercentOfFloat": 0.0038, "impliedSharesOutstanding": 157340992, "bookValue": -0.137, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1735516800, "netIncomeToCommon": -250474112, "trailingEps": -2.25, "forwardEps": -1.85, "enterpriseToRevenue": 19181.428, "enterpriseToEbitda": -21.868, "52WeekChange": -0.06194693, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 3.18, "targetHighPrice": 18.0, "targetLowPrice": 8.0, "targetMeanPrice": 12.16667, "targetMedianPrice": 12.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 131916000, "totalCashPerShare": 0.107, "ebitda": -183200560, "totalDebt": 222752000, "quickRatio": 1.525, "currentRatio": 1.571, "totalRevenue": 208859, "revenuePerShare": 0.0, "returnOnAssets": -0.73342, "grossProfits": 208859, "freeCashflow": -79297752, "operatingCashflow": -157809360, "revenueGrowth": -0.262, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -571.23486, "financialCurrency": "USD", "symbol": "OPT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Opthea Limited", "longName": "Opthea Limited", "regularMarketChangePercent": 2.5806506, "regularMarketPrice": 3.18, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "postMarketChangePercent": 0.0, "postMarketPrice": 3.18, "postMarketChange": 0.0, "regularMarketChange": 0.08000016, "regularMarketDayRange": "3.03 - 3.4503", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 34221, "fiftyTwoWeekLowChange": 1.3900001, "fiftyTwoWeekLowChangePercent": 0.7765364, "fiftyTwoWeekRange": "1.79 - 6.3", "fiftyTwoWeekHighChange": -3.1200001, "fiftyTwoWeekHighChangePercent": -0.4952381, "fiftyTwoWeekChangePercent": -6.1946926, "earningsTimestamp": 1740691331, "earningsTimestampStart": 1740691331, "earningsTimestampEnd": 1740691331, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.25, "epsForward": -1.85, "epsCurrentYear": -0.32627, "priceEpsCurrentYear": -9.746529, "postMarketTime": 1741982707, "regularMarketTime": 1741982401, "exchange": "NMS", "messageBoardId": "finmb_2482138", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "marketState": "CLOSED", "fiftyDayAverageChange": -1.2570398, "fiftyDayAverageChangePercent": -0.28330594, "twoHundredDayAverageChange": -0.309505, "twoHundredDayAverageChangePercent": -0.08869596, "priceToBook": -23.21168, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Opthea", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]